Sun Pharma

Programme records participation across premier management institutes and announces teams recognised in the grand finale

Sun Pharmaceutical announced the US Food and Drug Administration (FDA) approved an updated  label for UNLOXCYT (cosibelimab-ipdl)…

Sun Pharma announced the launch of its #SeeBeyondSugar campaign, a nationwide awareness and education initiative on Diabetic…

AstraZeneca Pharma India (‘AstraZeneca’), a leading science-led biopharmaceutical company and Sun Pharmaceutical Industries,…

As the world evolves at a rapid pace, pharma companies are embracing smarter approaches, leveraging AI across nearly every aspect…

US President Trump's fresh salvo of 100 per cent tariffs on branded or patented pharmaceutical products not ‘Made in America’…

Treatment with tildrakizumab 100 mg (ILUMYA) resulted in greater improvements in PsA signs and symptoms at Week 24 compared to…

Eli Lilly’s clinical data with orforglipron in patients with diabetes supports the drug’s potential as an obesity treatment, as…

Dilip Shanghvi will continue as the Executive Chairman of the Board, while Richard Ascroft joins Sun Pharma as CEO – North…

The first panel discussion of the day, titled 'From factory to patient: Just-in-time deliveries,' brought together a powerhouse of…